BIOVERATIV INC (BIVV) Stock Price, Forecast & Analysis

USA • Nasdaq • NASDAQ:BIVV

104.98
+0.33 (+0.32%)
At close: Mar 8, 2018
104.98
0 (0%)
After Hours: 3/8/2018, 8:22:33 PM

BIVV Key Statistics, Chart & Performance

Key Statistics
Market Cap11.36B
Revenue(TTM)1.17B
Net Income(TTM)355.60M
Shares108.22M
FloatN/A
52 Week High105.01
52 Week Low48.14
Yearly Dividend0
Dividend Yield0%
EPS(TTM)3.28
PE32.03
Fwd PE27.48
Earnings (Next)N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
BIVV short term performance overview.The bars show the price performance of BIVV in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60 80 100

BIVV long term performance overview.The bars show the price performance of BIVV in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80

The current stock price of BIVV is 104.98 null. In the past month the price increased by 1.67%. In the past year, price increased by 98.11%.

BIOVERATIV INC / BIVV Daily stock chart

BIVV Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to BIVV. When comparing the yearly performance of all stocks, BIVV is one of the better performing stocks in the market, outperforming 97.96% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

BIVV Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to BIVV. BIVV has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BIVV Financial Highlights

Over the last trailing twelve months BIVV reported a non-GAAP Earnings per Share(EPS) of 3.2774. The EPS decreased by -19.48% compared to the year before.


Industry RankSector Rank
PM (TTM) 30.43%
ROA 21.97%
ROE 39.62%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)-19.48%
Revenue 1Y (TTM)31.68%

BIVV Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y16.56%
Revenue Next YearN/A

BIVV Ownership

Ownership
Inst Owners97.18%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About BIVV

Company Profile

Bioverativ Inc. is a biotechnology company. It focuses on the discovery, research, development, and commercialization of innovative therapies for the treatment of hemophilia and other blood disorders. Bioverativ Inc. is based in Waltham, United States.

Company Info

BIOVERATIV INC

225 2ND AVENUE

WALTHAM MA 02451

CEO: John G. Cox

Phone: 781-663-4400

BIOVERATIV INC / BIVV FAQ

What does BIVV do?

Bioverativ Inc. is a biotechnology company. It focuses on the discovery, research, development, and commercialization of innovative therapies for the treatment of hemophilia and other blood disorders. Bioverativ Inc. is based in Waltham, United States.


Can you provide the latest stock price for BIOVERATIV INC?

The current stock price of BIVV is 104.98 null. The price increased by 0.32% in the last trading session.


Does BIOVERATIV INC pay dividends?

BIVV does not pay a dividend.


How is the ChartMill rating for BIOVERATIV INC?

BIVV has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Should I buy BIVV stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BIVV.


Can you provide the market cap for BIOVERATIV INC?

BIOVERATIV INC (BIVV) has a market capitalization of 11.36B null. This makes BIVV a Large Cap stock.